The New York Entrepreneur

Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future

Read Time:5 Second

Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post GM and Hyundai agree to explore collaboration on vehicles and manufacturing to reduce capital spending
Next post Moderna slashes research spending, trims pipeline as it looks to regain footing